This T32 training program, which is closely associated with the University of Minnesota adult Infectious Diseases physician fellowship program, is designed to prepare MD, MD/PhD, and other post- doctoral trainees for successful careers as clinical, epidemiological, and translational investigators in Infectious Diseases. There is a focus on emerging / reemerging infections and global health. The program has 4 post-doctoral slots per year and on average accepts 2 new trainees annually, usually following an initial year of clinical Infectious Diseases training. Trainees undergo a 2-to-3 year intensive research experience, either locally or at an affiliated international site, supervised by one or more of 27 expert faculty mentors who represent diverse disciplines and departments within the Medical School, School of Public Health, College of Pharmacy, and College of Veterinary Medicine. Trainees participate in didactics (including in Responsible Conduct of Research, biostatistics, and grant-writing), a journal club, and a research conference series, plus local, regional, and national Infectious Diseases conferences. Trainees can obtain an MS-Clinical Research degree or an MPH in Epidemiology, can take individual courses within the School of Public Health, and can take a Global Health course that qualifies them to sit for the American Society of Tropical Medicine & Hygiene (ASTMH) Certificate examination in Tropical Medicine (CTropMed). Oversight of trainee progress is by the Program Director and a Scholarship Oversight Committee, which meets semiannually with each trainee. Trainee selection and program governance are by the Program Director and a Steering / Selection Committee. Continuous program improvement is guided by feedback from current and former trainees, the Scholarship Oversight Committee, and an External Advisory Committee. Of the 32 total T32 trainees to date, 17 (53%) were women, 5 (16%) were under- represented minorities, and 2 (6%) have had disabilities requiring accommodations. Five fellows still are in training, and of the program's 27 graduates, 12 (44%) now have research-intensive careers with ?75% research effort; another 8 (30%) have research-related academic careers. Overall, 7 (26%) have been awarded NIH K Career Development Award (CDAs), VA CDAs, or a Foundation CDA, and another 4 (15%) have K08 or K23 applications currently submitted, 5 (18.5%) have R01, U01, VA Merit, or VA Cooperative Studies Program awards as the PI. Program graduates have disseminated to 7 states, mostly in the upper Midwest.

Public Health Relevance

This T32 training program is designed to train new clinical, epidemiological, and translational infectious disease investigators, who are needed to discover better ways to diagnose, treat, and prevent serious emerging and re-emerging infections and other Global Health threats such as HIV/AIDS, influenza, meningitis, and antimicrobial-resistant infections. The program draws on multiple schools and colleges within the University of Minnesota, plus a Global Health course and an international site, to provide post-doctoral trainees ? primarily Infectious Disease physicians ? with the advanced skills needed for a successful career in infectious diseases research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
2T32AI055433-16
Application #
9855164
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Coomes, Stephanie
Project Start
2003-09-01
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
16
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Pragman, Alexa A; Lyu, Tianmeng; Baller, Joshua A et al. (2018) The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome 6:7
Bahr, Nathan C; Nuwagira, Edwin; Evans, Emily E et al. (2018) Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis 18:68-75
Bahr, Nathan C; Halupnick, Ryan; Linder, Grace et al. (2018) Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis. Biomark Med 12:707-716
Rhein, Joshua; Hullsiek, Kathy H; Evans, Emily E et al. (2018) Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation. Open Forum Infect Dis 5:ofy122
Abassi, Mahsa; Rhein, Joshua; Meya, David B et al. (2018) Cryptococcal Disease in the Era of ""Test and Treat"": Is There Cause for Concern? Open Forum Infect Dis 5:ofx274
Lofgren, Sarah M; Nakasujja, Noeline; Boulware, David R (2018) Systematic Review of Interventions for Depression for People Living with HIV in Africa. AIDS Behav 22:1-8
Ellis, Jayne; Cresswell, Fiona V; Joshua, Rhein et al. (2018) Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan Adults. Open Forum Infect Dis 5:ofy193
Bahr, Nathan C; Lee, Deborah; Stauffer, William M et al. (2018) Seroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya. J Immigr Minor Health 20:334-338
Kajumbula, Henry; Fujita, Ayako Wendy; Mbabazi, Olive et al. (2018) Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda. Emerg Infect Dis 24:174-175
Yared, Nicholas; Horvath, Keith; Fashanu, Oluwaseun et al. (2018) Optimizing Screening for Sexually Transmitted Infections in Men Using Self-Collected Swabs: A Systematic Review. Sex Transm Dis 45:294-300

Showing the most recent 10 out of 85 publications